logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Lung Neoplasms

    FiltersReset Filters
    7 results
    • aminocaproic acid

      (Aminocaproic acid)
      BPI LABS LLC
      Usage: Aminocaproic acid oral solution enhances hemostasis in cases where fibrinolysis causes bleeding, particularly post-heart surgery, in hematological disorders, and during acute conditions like abruptio placentae. It may also address excessive urinary tract bleeding after surgeries or due to kidney-related diseases.
    • aminocaproic acid

      (AMINOCAPROIC ACID)
      Carnegie Pharmaceuticals, LLC
      Usage: Aminocaproic acid enhances hemostasis in cases of fibrinolysis-related bleeding, particularly during heart surgery, in hematological disorders, and during severe conditions like abruptio placentae and certain cancers. It also addresses excessive urinary tract bleeding associated with surgical or nonsurgical hematuria.
    • aminocaproic acid

      (AMINOCAPROIC ACID)
      PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
      Usage: Aminocaproic acid is indicated for enhancing hemostasis in cases of bleeding due to fibrinolysis, especially following heart surgeries, in hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary tract bleeding related to surgical or nonsurgical hematuria.
    • docetaxel

      (DOCETAXEL ANHYDROUS)
      Hospira, Inc.
      Usage: Docetaxel Injection is indicated for treating locally advanced or metastatic breast cancer, non-small cell lung cancer, metastatic castration-resistant prostate cancer, advanced gastric adenocarcinoma, and locally advanced squamous cell carcinoma of the head and neck. It is often used in combination with other chemotherapy agents.
    • etoposide

      (Etoposide)
      Meitheal Pharmaceuticals Inc.
      Usage: Etoposide Injection is indicated for managing refractory testicular tumors in conjunction with other chemotherapy agents and as a first-line treatment for small cell lung cancer, also in combination with approved chemotherapeutic agents.
    • methotrexate

      (METHOTREXATE SODIUM)
      Fresenius Kabi USA, LLC
      Usage: Methotrexate is indicated for treating various neoplastic diseases, including choriocarcinoma, leukemia, breast cancer, and advanced lymphomas, as well as for severe psoriasis and rheumatoid arthritis, particularly in patients unresponsive to first-line therapies. Proper diagnosis and monitoring are essential for effective treatment.
    • methotrexate

      (Methotrexate)
      Hikma Pharmaceuticals USA Inc.
      Usage: Methotrexate is indicated for treating neoplastic diseases such as gestational choriocarcinoma, leukemias, various cancers (breast, head and neck, lung), advanced non-Hodgkin’s lymphomas, severe psoriasis, and rheumatoid arthritis in patients unresponsive to first-line therapies. It is used alone or in combination with other agents.